Clinical Trial Update: Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a rectal insert containing tenofovir alafenamide and elvitegravir for HIV prevention has completed, with safety issues reported during …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Rectal Insert TAF/EVG (tenofovir alafenamide/elvitegravir rectal insert)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Safety Issues | Phase 1 | Status: COMPLETED